Metropolis Healthcare Ltd

At Metropolis Labs, we are committed to bringing new testing technologies that will assist doctors in making better clinical decisions and treatments, thereby enhancing the quality of patient care. In this direction, we are pleased to announce the #NextGenHLA Typing Test, which is powered by the complex molecular technology #nextgenerationsequencing (NGS). Metropolis' NextGen HLA Typing is a molecular test, which is performed for Bone Marrow Transplantation, also known as Hematopoietic Stem Cell Transplant (HSCT) & in Solid organ transplants such as Kidney transplants. This test aids in the identification of a suitable donor for bone marrow, cord blood, or organ transplant by analysing the Human Leukocyte Antigen (HLA) genes that a person has inherited from the parents. We believe that this test will help doctors find the right donors for their patients, resulting in successful transplants and higher survival rates. Metropolis Healthcare has established a centre of excellence for all transplant-related diagnostic services over the years, including the most comprehensive array of diagnostic tools, reports with more accurate interpretation, expert laboratory professionals, and subject matter specialists, making Metropolis a one-stop solution for all the transplant-related diagnostic needs. #MetropolisLab #Healthcare #DiagnosticLeader #Innovation #MetropolisScientificExpert #MolecularGenomicshttps://indiamedtoday.com/metropolis-launches-nextgen-hla-test-for-hsct-solid-organ-transplantation/ #NextGenHLA #nextgenerationsequencing #MetropolisLab #Healthcare #DiagnosticLeader #Innovation #MetropolisScientificExpert #MolecularGenomics

Diagnostics tools can play a crucial role in building the pathway for better health outcomes for women by facilitating early disease detection and empowering them with awareness. Check out this cover story by Kalyani Sharma of Express Healthcare in which Ms. Ameera Shah, Managing Director, Metropolis Labs joins leading clinicians and other industry experts to share her views on the Diagnostics for Women’s Health. Ameera highlights that investing in healthcare infrastructure in rural areas, including building and upgrading healthcare facilities, can help to increase access to diagnostic tests for women in these areas. #MetropolisLab #Healthcare #DiagnosticLeader #ScientificExcellence #WomenHealth #Technologies #NextGenBRCA #MolecularDiagnosticshttps://www.expresshealthcare.in/news/diagnostics-for-womens-health-coming-of-age/438383/ #MetropolisLab #Healthcare #DiagnosticLeader #ScientificExcellence #WomenHealth #Technologies #NextGenBRCA #MolecularDiagnostics

In a freewheeling interview with Prabhat Prakash of ETHealthworld, Metropolis Labs Managing Director Ms. Ameera Shah spoke in-depth about the volumes, revenues, price-capping in Covid testing, market disruption by new age tech players & the newer technologies in the diagnostic sector. Ameera also emphasized that the government’s focus on the private healthcare sector is extremely crucial by building on the right policies so as to ensure that minimum quality standards are maintained. Check out the link below to read the full interview. #MetropolisLab #Healthcare #DiagnosticLeader #ThoughtLeader #HealthcareLeader #HealthcareInfluentialWoman #Growth #Diagnostics #Covidtesting #Quality #PatientSafety #Care #Newertechnologies #ScientificExperthttps://health.economictimes.indiatimes.com/news/industry/healthcare-not-an-electoral-subject-votes-arent-cast-on-basis-of-providing-good-healthcare/98600689 #MetropolisLab #Healthcare #DiagnosticLeader #ThoughtLeader #HealthcareLeader #HealthcareInfluentialWoman #Growth #Diagnostics #Covidtesting #Quality #PatientSafety #Care #Newertechnologies #ScientificExpert

Watch Now: In this episode of the popular health show #Sehat of The Lallantop, Metropolis Labs Chief Scientific Officer Dr Kirti Chadha takes us through the processes followed by a technician in a path lab, as soon as the blood sample is received. In this video, she also throws light on the use of different devices and equipments, and explains how the report goes under multiple quality checks and expert review, before it is finally shared with the patient. Location Courtesy: #MetropolisDelhiReferenceLaboratory #MetropolisLab #Healthcare #Diagnosis #DiagnosticLeader #Scientificexpert #Quality #Smartreports #PatientSafetyhttps://www.youtube.com/watch?v=y1hADNUzPhA #Sehat #MetropolisDelhiReferenceLaboratory #MetropolisLab #Healthcare #Diagnosis #DiagnosticLeader #Scientificexpert #Quality #Smartreports #PatientSafety

According to an Indian Council of Medical Research (ICMR) study, one in nine Indians are likely to develop cancer in their lifetime. It is not women who are being affected with cancer, men are also equally at risk with the cancer prevalence continually showing an upward trend among them. Here’s an article authored by Dr Shaikhali Barodawala, Scientific and Business Head, Integrated Oncopathology, Consultant and Head, Anatomic Pathology, Global Reference Laboratory, Metropolis Labs, in which he briefly highlights on the most common cancer symptoms for men in order to seek timely care and detection. #MetropolisLabs #MetropolisScientificExpert #Healthcare #Oncomet #SuperSpeciality #CancerDiagnosis #Oncology #DiagnosticLeaderhttps://health.economictimes.indiatimes.com/news/industry/minimizing-the-fear-of-unknown-mens-common-cancer-symptoms/98036165 #MetropolisLabs #MetropolisScientificExpert #Healthcare #Oncomet #SuperSpeciality #CancerDiagnosis #Oncology #DiagnosticLeader

As we await to hear the #unionbudget2023 tomorrow, Ms. Ameera Shah, Promoter and MD, Metropolis Labs joins other diagnostic industry players to share her expectations from the Union Budget with #ETHealthWorld. Sharing here the excerpts of her quote: “As we prepare for the post-pandemic era, it is crucial to boost the economy through building and preparing a healthcare infrastructure so that people have greater access to quality and critical healthcare services. To achieve this vision, the Union Budget 2023-2024 should help fuel innovation, R&D, and healthcare expenditure as an investment into future human capital, which will set the pace for propelling the industry forward. The government should consider zero-rating GST on healthcare services. It will ensure eligibility for input tax credits, which may help to reduce the cost of said services, and a refund of unutilized input tax credits should also be allowed to provide additional working capital to industry players. The input credit for GST paid can enable the healthcare providers to pass it on to the patients in the form of lower pricing and the services can be made accessible to patients in smaller towns. Along with this, it is important to address the shortage of healthcare professionals (doctors, nurses, and technical staff) willing to work in Tier 2/3 cities and look at non-traditional ways to double the number of doctors. In addition, the government should prioritize lower-cost financing through tax breaks for both existing and new healthcare projects. Also, they should provide a 15-year tax holiday for new projects and a 10-year tax break for existing projects as reinvestment support. Declaring healthcare, a national priority sector and classifying it along the same lines as agriculture (priority-sector lending) will allow banks to lend to private healthcare institutions for longer periods of time and at lower interest rates. The future of healthcare has enormous opportunities for India to become a global healthcare destination.” Check out the link to read the entire article. #MetropolisLabs #Healthcare #Diagnostics #DiagnosticLeaderhttps://health.economictimes.indiatimes.com/news/diagnostics/union-budget-2023-24-make-diagnostics-cost-effective-with-gst-exemption/97453694 #unionbudget2023 #ETHealthWorld #MetropolisLabs #Healthcare #Diagnostics #DiagnosticLeader

“Metropolis Healthcare is in a Sweet Spot,” says our MD Ms. Ameera Shah in a #BusinessTodayshow with Udayan Mukherjee (Global Business Editor of Business Today). Check out the full interview here as Ms. Ameera Shah talks about the growth synergies in the sector and shares her view on the demand scenario in the Indian diagnostics space. #MetropolisLabs #Healthcare #Diagnosticleader #Pathologypathbreaker Video Courtesy: #udayanmukherjeeshow #BusinessTodayhttps://youtu.be/BYPRCp8Rx-4 #BusinessTodayshow #MetropolisLabs #Healthcare #Diagnosticleader #Pathologypathbreaker #udayanmukherjeeshow #BusinessToday

We are excited to inform you that Metropolis Labs Chief Scientific Officer and Group Head - CSR, Dr Kirti Chadha will be addressing a panel discussion at the #IndiaCSRSummit2022. She will be speaking on the topic 'Role of Tech for Impact in Healthcare Delivery (Health Tech for Good)' Team Metropolis wishes her good luck for the session! #ics2022 #Metropolislabs #MetropolisFoundation #MHLCSRImpact #Leadership #ESG #Sustainability #DiagnosticLeader #thoughtleadership #UNSustainableDevelopmentGoals #MedEngage #TooShytoAsk #Healthcare #patientcare #Techology #Empowerment #Educate #Engage #IndiaCSRSummit2022 #ics2022 #Metropolislabs #MetropolisFoundation #MHLCSRImpact #Leadership #ESG #Sustainability #DiagnosticLeader #thoughtleadership #UNSustainableDevelopmentGoals #MedEngage #TooShytoAsk #Healthcare #patientcare #Techology #Empowerment #Educate #Engage